Argus has recently raised AbbVie Inc (ABBV) stock to Buy rating, as announced on November 4, 2024, according to Finviz. Earlier, on October 17, 2024, Bernstein had initiated the stock to Mkt Perform, ...

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Is Arcellx, Inc. (ACLX) one of those stocks right now? A quick ...

Neurocrine Biosciences, Inc.'s potential for growth in the biopharma sector is strong despite recent setbacks, making its ...

AbbVie has announced its second major takeover deal in the space of a few days, offering $8.7 billion to buy central nervous system drug specialist Cerevel Therapeutics, which spun out of Pfizer ...

Phuket’s tropical charm has once again worked its magic, landing it among Asia’s Top 10 island destinations, as revealed by the esteemed Condé Nast Traveler Readers’ Choice Awards. UK tabloid Daily ...

A new piranha species was recently discovered in the Amazon which resembles the fiery eye symbol for the villain Sauron from J.R.R. Tolkien’s “The Lord of the Rings” book and film series. An ...